The Long Run with Luke Timmerman
Timmerman Report
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Mentioned books
Jun 21, 2018 • 1h 2min
Ep21: Tony Coles
Tony Coles on neurodegenerative drug discovery and inclusive leadership.
Jun 4, 2018 • 1h 4min
Ep20: Rob Perez
Ep20: Rob Perez by Timmerman Report
May 9, 2018 • 1h 5min
Ep19: Chip Clark
Ep19: Chip Clark by Timmerman Report
May 9, 2018 • 1h 4min
Ep18: Ethan Perlstein
Ep18: Ethan Perlstein by Timmerman Report
Apr 24, 2018 • 58min
Ep17: Alice Zhang
Ep17: Alice Zhang by Timmerman Report
Mar 13, 2018 • 1h 1min
Ep14: Michael Gilman
Michael Gilman on becoming an entrepreneur.
Feb 28, 2018 • 58min
Ep13: Bruce Booth
Bruce Booth on human capital
Feb 13, 2018 • 59min
Ep12: David Schenkein
Agios CEO David Schenkein on building a cancer R&D engine to last.
Jan 31, 2018 • 1h 6min
Ep11: Stephane Bancel
Stephane Bancel, CEO of Moderna Therapeutics, on his influences.
Jan 16, 2018 • 52min
Ep10: Abbie Celniker
Abbie Celniker of Third Rock Ventures on her career, and chipping away at gender inequities in biotech.


